Rubella Humoral Immunity Among the Saudi Population of Madinah in the Western Region of Saudi Arabia
- PMID: 35537526
- DOI: 10.1089/vim.2021.0226
Rubella Humoral Immunity Among the Saudi Population of Madinah in the Western Region of Saudi Arabia
Abstract
Maintaining herd immunity against the rubella virus is important for controlling the spread and recurrence of rubella. Rubella vaccination for children has been affordable in Saudi Arabia since 1982. To assess the immune response derived from vaccination, we assessed the seroprevalence against the rubella virus among the population of the Madinah region. An indirect enzyme-linked immunosorbent assay (ELISA) was used to measure anti-rubella IgG antibodies in 791 serum samples obtained from 336 (42.5%) men and 455 (57.5%) women, ranging from 14 to 49 years in age. Among all participants, 94.2% were seropositive for rubella IgG antibodies, indicating a high degree of immunization. However, 5.8% of participants were seronegative, suggesting a population of either poor vaccine responders or the potential risk of waning vaccine-induced immunity. No significant difference or association with rubella seropositivity was identified according to age, sex, or pregnancy status. The median anti-rubella IgG antibody concentrations differed significantly between age groups (p < 0.001). Although a high percentage of the tested population in Madinah demonstrated anti-rubella IgG antibody seropositivity, a notable percentage of the population were seronegative, making them susceptible to infection.
Keywords: IgG antibody; MMR vaccine; Madinah; rubella virus; seropositivity.
Similar articles
-
Serostatus of IgG antibody against mumps virus in adult population of Al Madinah Al Munawarah, Saudi Arabia.Saudi Med J. 2021 Aug;42(8):862-868. doi: 10.15537/smj.2021.42.8.20210228. Saudi Med J. 2021. PMID: 34344810 Free PMC article.
-
Seroprevalence against the measles virus after vaccination or natural infection in an adult population in Madinah, Saudi Arabia.Hum Vaccin Immunother. 2021 Aug 3;17(8):2522-2529. doi: 10.1080/21645515.2021.1876486. Epub 2021 Feb 11. Hum Vaccin Immunother. 2021. PMID: 33573436 Free PMC article.
-
Seroprevalence and durability of rubella virus antibodies in a highly immunized population.Vaccine. 2019 Jun 27;37(29):3876-3882. doi: 10.1016/j.vaccine.2019.05.049. Epub 2019 May 21. Vaccine. 2019. PMID: 31126859 Free PMC article.
-
Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.J Med Virol. 2020 Aug;92(8):963-970. doi: 10.1002/jmv.25665. Epub 2020 Feb 3. J Med Virol. 2020. PMID: 31919861
-
Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.Vaccine. 2020 Jan 29;38(5):1249-1257. doi: 10.1016/j.vaccine.2019.11.004. Epub 2019 Nov 12. Vaccine. 2020. PMID: 31732325 Free PMC article.
Cited by
-
Serosurveillance for Measles and Rubella.Vaccines (Basel). 2024 Jul 22;12(7):816. doi: 10.3390/vaccines12070816. Vaccines (Basel). 2024. PMID: 39066453 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical